Royal London Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.43M | Sell |
178,471
-3,073
| -2% | -$111K | 0.01% | 520 |
|
|
2025
Q1 | $5.65M | Buy |
181,544
+3,849
| +2% | +$120K | 0.01% | 550 |
|
|
2024
Q4 | $4.53M | Buy |
177,695
+17,511
| +11% | +$447K | 0.01% | 561 |
|
|
2024
Q3 | $4.53M | Buy |
160,184
+4,307
| +3% | +$122K | 0.01% | 563 |
|
|
2024
Q2 | $4.11M | Sell |
155,877
-183,688
| -54% | -$4.84M | 0.01% | 568 |
|
|
2024
Q1 | $10.3M | Buy |
339,565
+17,769
| +6% | +$540K | 0.03% | 395 |
|
|
2023
Q4 | $9.04M | Buy |
321,796
+3,282
| +1% | +$92.2K | 0.03% | 401 |
|
|
2023
Q3 | $8.65M | Buy |
318,514
+52,524
| +20% | +$1.43M | 0.03% | 399 |
|
|
2023
Q2 | $8.17M | Buy |
265,990
+123,566
| +87% | +$3.8M | 0.03% | 401 |
|
|
2023
Q1 | $5.13M | Buy |
142,424
+14,803
| +12% | +$533K | 0.02% | 468 |
|
|
2022
Q4 | $5.04M | Buy |
127,621
+7,612
| +6% | +$301K | 0.02% | 451 |
|
|
2022
Q3 | $4.82M | Sell |
120,009
-3,979
| -3% | -$160K | 0.02% | 438 |
|
|
2022
Q2 | $5.22M | Hold |
123,988
| – | – | 0.02% | 437 |
|
|
2022
Q1 | $4.83M | Buy |
123,988
+5,904
| +5% | +$230K | 0.02% | 511 |
|
|
2021
Q4 | $4.71M | Hold |
118,084
| – | – | 0.02% | 508 |
|
|
2021
Q3 | $4.27M | Hold |
118,084
| – | – | 0.02% | 535 |
|
|
2021
Q2 | $4.84M | Hold |
118,084
| – | – | 0.02% | 523 |
|
|
2021
Q1 | $5.15M | Buy |
+118,084
| New | +$5.15M | 0.02% | 486 |
|